Profile of gantenerumab and its potential in the treatment of Alzheimer's disease
Dijana Novakovic,1 Marco Feligioni,2 Sergio Scaccianoce,1 Alessandra Caruso,1 Sonia Piccinin,2 Chiara Schepisi,1,2 Francesco Errico,3 Nicola B Mercuri,4 Ferdinando Nicoletti,1,5 Robert Nisticò1,41Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy; 2Europea...
Saved in:
Main Authors: | Novakovic D (Author), Feligioni M (Author), Scaccianoce S (Author), Caruso A (Author), Piccinin S (Author), Schepisi C (Author), Errico F (Author), Mercuri NB (Author), Nicoletti F (Author), Nisticò R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
by: Novakovic D, et al.
Published: (2014) -
Risk Factors for Alzheimer's Disease: Focus on Stress
by: Alessandra Caruso, et al.
Published: (2019) -
Disease-modifying drugs in Alzheimer's disease
by: Ghezzi L, et al.
Published: (2013) -
Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease
by: Dalila Mango, et al.
Published: (2019) -
Towards a 'canonical' agranular cortical microcircuit
by: Sarah F. Beul, et al.
Published: (2015)